Ugo de Sanctis

Ugo de Sanctis

Auto-generated profile, based on publicly available information

Ugo de Sanctis

Department of Surgical Sciences, Eye Clinic, University of Turin, Turin, Italy

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2008 in Ophthalmology
Verified
Journal Article
Closed access
USUgo de Sanctis
Ugo de Sanctis
CLCarlotta Loiacono
Carlotta Loiacono
LRLorenzo Richiardi
Lorenzo Richiardi
DTDavide Turco
Davide Turco
BMBernardo Mutani
Bernardo Mutani
FGFederico M. Grignolo
Federico M. Grignolo

5 April 2005 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
NRNicola K. Ragge
Nicola K. Ragge
BLBirgit Lorenz
Birgit Lorenz
ASAdele Schneider
Adele Schneider
KBKate Bushby
Kate Bushby
Luisa de SanctisLuisa de Sanctis
Luisa de Sanctis
DFDavid R. FitzPatrick
David R. FitzPatrick

1 November 2007 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
USUgo de Sanctis
Ugo de Sanctis
AMAlessandro Missolungi
Alessandro Missolungi
BMBernardo Mutani
Bernardo Mutani
LRLorenzo Richiardi
Lorenzo Richiardi
FGFederico M. Grignolo
Federico M. Grignolo

13 July 2017 in Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
CACamilla Alovisi
Camilla Alovisi
CPClaudio Panico
Claudio Panico
USUgo de Sanctis
Ugo de Sanctis
CEChiara M. Eandi
Chiara M. Eandi
Recent developments in vitreoretinal surgery have increased the need for suitable vitreous substitutes. A successful substitute should maintain all the physical and biochemical properties of the original vitreous, be easy to manipulate, and be long lasting. Substitutes can be gaseous or liquid, both of which have associated advantages and disadvantages related to their physical properties and use. Furthermore, new surgical techniques with smaller vitreoretinal instruments have driven the use of more viscous substitutes. In this review, we analyze and discuss the most frequently used vitreous substitutes and look ahead to future alternatives. We classify these compounds based on their composition and structure, discuss their clinical use with respect to their associated advantages and disadvantages, and analyze how new vitreoretinal surgical techniques have modified their use.

9 April 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
Francesco PetrilloFrancesco Petrillo
Francesco Petrillo
ATAntonia Tortori
Antonia Tortori
VVVeronica Vallino
Veronica Vallino
MGMarilena Galdiero
Marilena Galdiero
AFAntonio Maria Fea
Antonio Maria Fea
MRMichele Reibaldi
Michele Reibaldi
Acanthamoeba keratitis (AK) is a rare but potentially sight-threatening corneal infection caused by the Acanthamoeba parasite. This microorganism is found ubiquitously in the environment, often in freshwater, soil, and other sources of moisture. Despite its low incidence, AK presents significant challenges due to delayed diagnosis and the complex nature of therapeutic management. Early recognition is crucial to prevent severe ocular complications, including corneal ulceration and vision loss. Diagnostic modalities and treatment strategies may vary greatly depending on the clinical manifestation and the available tools. With the growing reported cases of Acanthamoeba keratitis, it is essential for the ophthalmic community to thoroughly understand this condition for its effective management and improved outcomes. This review provides a comprehensive overview of AK, encompassing its epidemiology, risk factors, pathophysiology, clinical manifestations, diagnosis, and treatment.

1 July 2013 in Cornea
Verified
Journal Article
Closed access
USUgo de Sanctis
Ugo de Sanctis
VAVittoria Aragno
Vittoria Aragno
PDPaola Dalmasso
Paola Dalmasso
LBLuca Brusasco
Luca Brusasco
FGFederico Grignolo
Federico Grignolo
To compare the efficacy of posterior corneal elevation, measured by 2 methods, in discriminating subclinical keratoconus from normal corneas. In 30 consecutive patients with subclinical keratoconus, and 37 candidates for refractive surgery, posterior corneal elevation was measured using Pentacam's rotating Scheimpflug camera (Oculus, Wetzlar, Germany) with the standard method [maximal elevation above the best fit sphere (BFS)] and with the enhanced-BFS (E-BFS) method (difference in elevation measured above the E-BFS and that measured above the BFS). Using cutoff points selected a priori (≥ 29 and ≥ 12 µm, respectively, for the standard and E-BFS methods) the sensitivity, specificity, and overall accuracy, determined through the area under the receiver operating characteristic curves, were assessed for each method and then compared. Mean posterior elevation values were statistically higher (P < 0.001) in corneas with subclinical keratoconus than in normal corneas, using either the standard (38 ± 15.9 µm vs. 20.3 ± 7.1 µm) or the E-BFS (15 ± 9.5 µm vs. 7.8 ± 5.5 µm) methods. Sensitivity and specificity rates were slightly higher with the standard method than with the E-BFS method (sensitivity, 73.3% vs. 60%; specificity, 86.5% vs. 83.8%), but neither difference was statistically significant (P > 0.05). The overall accuracy of the tests was similar (P = 0.19): the area under the curve was 0.80 for the standard and 0.72 for the E-BFS method. Posterior corneal elevation measured using either standard or E-BFS method has similar efficacy in discriminating corneas with subclinical keratoconus from normal corneas. As a single parameter, posterior elevation can be considered quite effective with either method, but it cannot be used alone to identify patients with subclinical keratoconus.